Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Kitagawa

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Mycobacteriology|March 21, 2017
Comparison of cost-effectiveness between the quantiFERON-TB Gold-In-Tube and T-Spot tests for screening health-care workers for latent tuberculosis infectionShigeto Mukai, Katsumi Shigemura, Fukashi Yamamichi, et al.
Cancer Gene Therapy|February 26, 2025
A conditionally replicative adenovirus vector containing the synNotch receptor gene for the treatment of muscle-invasive bladder cancerRuhan A, Hideto Ueki, Shunya Nishioka, et al.
Japanese Journal of Infectious Diseases|November 3, 2017
International Comparison of Causative Bacteria and Antimicrobial Susceptibilities of Urinary Tract Infections between Kobe, Japan, and Surabaya, IndonesiaKoichi Kitagawa, Katsumi Shigemura, Fukashi Yamamichi, et al.
Urologia Internationalis|January 3, 2019
Clinical Risk Factors for Death Caused by Extended-Spectrum Beta-Lactamase: Producing BacteriaYoshie Mita, Katsumi Shigemura, Kayo Osawa, et al.
Journal of Chemotherapy (Florence, Italy)|September 29, 2017
Comparison of antibiotics use, urinary tract infection (UTI)-causative bacteria and their antibiotic susceptibilities among 4 hospitals with different backgrounds and regions in JapanKatsumi Shigemura, Koichi Kitagawa, Kayo Osawa, et al.
Molecular Cancer Therapeutics|March 3, 2019
Preclinical Development of a WT1 Oral Cancer Vaccine Using a Bacterial Vector to Treat Castration-Resistant Prostate CancerKoichi Kitagawa, Reina Gonoi, Maho Tatsumi, et al.
Antibiotics (Basel, Switzerland)|November 27, 2021
Effect of Antimicrobial Stewardship on Oral Quinolone Use and Resistance Patterns over 8 Years (2013-2020)Atsushi Uda, Katsumi Shigemura, Koichi Kitagawa, et al.
Journal of Bioscience and Bioengineering|October 5, 2019
Nanaomycin K, a new epithelial-mesenchymal transition inhibitor produced by the actinomycete "Streptomyces rosa subsp. notoensis" OS-3966Hirotaka Matsuo, Jun Nakanishi, Yoshihiko Noguchi, et al.
Scientific Reports|April 29, 2021
Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivoKoichi Kitagawa, Katsumi Shigemura, Aya Ishii, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 5, 2020
Genetic analysis of ESBL-producing Klebsiella pneumoniae isolated from UTI patients in IndonesiaSaya Yamasaki, Katsumi Shigemura, Kayo Osawa, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Mycobacteriology|March 21, 2017
Comparison of cost-effectiveness between the quantiFERON-TB Gold-In-Tube and T-Spot tests for screening health-care workers for latent tuberculosis infectionShigeto Mukai, Katsumi Shigemura, Fukashi Yamamichi, et al.
Cancer Gene Therapy|February 26, 2025
A conditionally replicative adenovirus vector containing the synNotch receptor gene for the treatment of muscle-invasive bladder cancerRuhan A, Hideto Ueki, Shunya Nishioka, et al.
Japanese Journal of Infectious Diseases|November 3, 2017
International Comparison of Causative Bacteria and Antimicrobial Susceptibilities of Urinary Tract Infections between Kobe, Japan, and Surabaya, IndonesiaKoichi Kitagawa, Katsumi Shigemura, Fukashi Yamamichi, et al.
Urologia Internationalis|January 3, 2019
Clinical Risk Factors for Death Caused by Extended-Spectrum Beta-Lactamase: Producing BacteriaYoshie Mita, Katsumi Shigemura, Kayo Osawa, et al.
Journal of Chemotherapy (Florence, Italy)|September 29, 2017
Comparison of antibiotics use, urinary tract infection (UTI)-causative bacteria and their antibiotic susceptibilities among 4 hospitals with different backgrounds and regions in JapanKatsumi Shigemura, Koichi Kitagawa, Kayo Osawa, et al.
Molecular Cancer Therapeutics|March 3, 2019
Preclinical Development of a WT1 Oral Cancer Vaccine Using a Bacterial Vector to Treat Castration-Resistant Prostate CancerKoichi Kitagawa, Reina Gonoi, Maho Tatsumi, et al.
Antibiotics (Basel, Switzerland)|November 27, 2021
Effect of Antimicrobial Stewardship on Oral Quinolone Use and Resistance Patterns over 8 Years (2013-2020)Atsushi Uda, Katsumi Shigemura, Koichi Kitagawa, et al.
Journal of Bioscience and Bioengineering|October 5, 2019
Nanaomycin K, a new epithelial-mesenchymal transition inhibitor produced by the actinomycete "Streptomyces rosa subsp. notoensis" OS-3966Hirotaka Matsuo, Jun Nakanishi, Yoshihiko Noguchi, et al.
Scientific Reports|April 29, 2021
Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivoKoichi Kitagawa, Katsumi Shigemura, Aya Ishii, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 5, 2020
Genetic analysis of ESBL-producing Klebsiella pneumoniae isolated from UTI patients in IndonesiaSaya Yamasaki, Katsumi Shigemura, Kayo Osawa, et al.
Pageof 8